×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACHV – achieve life sciences, inc. - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACHV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/4
09:00 pm
achv
Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch [Seeking Alpha]
Medium
Report
Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch [Seeking Alpha]
2/4
02:46 am
achv
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy [Seeking Alpha]
Low
Report
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy [Seeking Alpha]
2/2
07:41 pm
achv
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory [Yahoo! Finance]
Medium
Report
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory [Yahoo! Finance]
1/30
04:05 pm
achv
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Low
Report
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
1/17
08:28 am
achv
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future [Yahoo! Finance]
Medium
Report
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future [Yahoo! Finance]
1/12
08:47 am
achv
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
Low
Report
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
12/30
04:09 pm
achv
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
12/23
04:09 pm
achv
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
07:00 am
ACHV
achieve life sciences, inc. - common shares
MISS
Report
-4.4%
achieve life sciences, inc. - common shares
8/7/2025
07:30 am
ACHV
achieve life sciences, inc. - common shares
IN-LINE
Report
-4.3%
achieve life sciences, inc. - common shares
5/13/2025
07:30 am
ACHV
achieve life sciences, inc. - common shares
IN-LINE
Report
6.9%
achieve life sciences, inc. - common shares
3/11/2025
07:30 am
ACHV
achieve life sciences, inc. - common shares
MISS
Report
-5.5%
achieve life sciences, inc. - common shares
Date
Time
Symbol
Headline
Impact
1/30
04:10 pm
achv
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Rubinstein Mark Lawrence
Low
Report
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Rubinstein Mark Lawrence
1/30
04:09 pm
achv
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Oki Mark K
Low
Report
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Oki Mark K
1/30
04:08 pm
achv
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Xinos Jaime
Low
Report
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Xinos Jaime
1/30
04:07 pm
achv
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Donnelly Craig
Low
Report
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Donnelly Craig
1/30
04:06 pm
achv
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Stewart Richard Alistair
Low
Report
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Stewart Richard Alistair
1/30
04:05 pm
achv
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Wan Jerry
Low
Report
Form 4 ACHIEVE LIFE SCIENCES, For: Jan 28 Filed by: Wan Jerry
1/30
06:08 am
achv
Form EFFECT ACHIEVE LIFE SCIENCES,
Medium
Report
Form EFFECT ACHIEVE LIFE SCIENCES,
1/29
11:14 am
achv
Form SCHEDULE 13G/A ACHIEVE LIFE SCIENCES, Filed by: FRANKLIN RESOURCES INC
Low
Report
Form SCHEDULE 13G/A ACHIEVE LIFE SCIENCES, Filed by: FRANKLIN RESOURCES INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/30
Form 8-K ACHIEVE LIFE SCIENCES, For: Apr 27
35.3%
12/9 Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program 14.3%
5/28 Form 4 ACHIEVE LIFE SCIENCES, For: May 23 Filed by: Stewart Richard Alistair 11.6%
6/11 Achieve Life Sciences Inc (NASDAQ: ACHV) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $20.00 price target on the stock, up previously from $12.00. 9.2%
6/7 Form 3 ACHIEVE LIFE SCIENCES, For: May 30 Filed by: Armistice Capital Master Fund Ltd. 8.4%
8/12 Achieve Life Sciences Inc (NASDAQ: ACHV) was given a new $6.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. 7.3%
7/25 Form S-1 ACHIEVE LIFE SCIENCES, 5.7%
8/8 Form EFFECT ACHIEVE LIFE SCIENCES, 5.7%
12/26 Form SC 13G ACHIEVE LIFE SCIENCES, Filed by: CVI Investments, Inc. 5.7%
12/18 Form EFFECT ACHIEVE LIFE SCIENCES, 4.4%
12/9 Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program 14.3%
5/28 Form 4 ACHIEVE LIFE SCIENCES, For: May 23 Filed by: Stewart Richard Alistair 11.6%
6/11 Achieve Life Sciences Inc (NASDAQ: ACHV) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $20.00 price target on the stock, up previously from $12.00. 9.2%
6/7 Form 3 ACHIEVE LIFE SCIENCES, For: May 30 Filed by: Armistice Capital Master Fund Ltd. 8.4%
8/12 Achieve Life Sciences Inc (NASDAQ: ACHV) was given a new $6.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. 7.3%
7/25 Form S-1 ACHIEVE LIFE SCIENCES, 5.7%
8/8 Form EFFECT ACHIEVE LIFE SCIENCES, 5.7%
12/26 Form SC 13G ACHIEVE LIFE SCIENCES, Filed by: CVI Investments, Inc. 5.7%
12/18 Form EFFECT ACHIEVE LIFE SCIENCES, 4.4%
TOP News Decliners
12/17
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
-54.0%
3/13 Achieve Life Sciences EPS beats by $0.02 [Seeking Alpha] -21.8%
6/11 Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial -21.4%
11/6 Form S-1 ACHIEVE LIFE SCIENCES, -19.2%
3/12 Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting -16.1%
12/16 Form S-1/A ACHIEVE LIFE SCIENCES, -11.3%
12/23 Here's Why We're A Bit Worried About Achieve Life Sciences's (NASDAQ:ACHV) Cash Burn Situation [Yahoo! Finance News] -10.3%
9/30 Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study -9.6%
5/15 Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update -9.2%
2/6 Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users -8.6%
3/13 Achieve Life Sciences EPS beats by $0.02 [Seeking Alpha] -21.8%
6/11 Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial -21.4%
11/6 Form S-1 ACHIEVE LIFE SCIENCES, -19.2%
3/12 Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting -16.1%
12/16 Form S-1/A ACHIEVE LIFE SCIENCES, -11.3%
12/23 Here's Why We're A Bit Worried About Achieve Life Sciences's (NASDAQ:ACHV) Cash Burn Situation [Yahoo! Finance News] -10.3%
9/30 Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study -9.6%
5/15 Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update -9.2%
2/6 Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users -8.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: